You just read:

Tolero Pharmaceuticals to Expand Enrollment of Phase II Study of Alvocidib in MCL-1-Dependent AML into Europe

News provided by

Tolero Pharmaceuticals, Inc.

Jun 21, 2017, 08:38 ET